Chat with us, powered by LiveChat

Discuss

Explore topical blogs discussing chemical safety assessment.

The benefits of joining the Complex Nitrosamines consortium

The benefits of joining the Complex Nitrosamines consortium

Data sharing initiatives allow researchers and scientists to share data and knowledge in order to improve and accelerate scientific progress and discovery. These initiatives are therefore at the heart of our Lhasa Limited ethos “Shared knowledge, shared progress“. In response to the nitrosamine crisis, we partnered with the pharmaceutical industry to launch a data sharing […]

The benefits of joining the Complex Nitrosamines consortium Read More »

member benefits blog image

Passion meets purpose: The benefits of being a Lhasa Limited member

“Upon becoming a member of Lhasa Limited, a world of opportunity opened up, both for the acquisition of new tools and for opportunities to actively participate in the consortia promoted by Lhasa, where there is a very important exchange of knowledge between professionals in the field.” Mariah Ultramari, Spektra Consultoria At Lhasa, we’re proud to

Passion meets purpose: The benefits of being a Lhasa Limited member Read More »

Lhasa Limited CEO Dr. Chris Barber reflects on 2020 and shares plans for the year ahead

Lhasa Limited CEO, Dr. Chris Barber, reflects on 2020 and shares plans for the year ahead

The global pandemic has undoubtedly had a huge impact on many companies in 2020, Lhasa is no exception. I am immensely proud of my Lhasa colleagues’ resilience during the remote working situation we all found ourselves in, demonstrated, in part, through the continued release of both software and knowledge to our members throughout 2020. If

Lhasa Limited CEO, Dr. Chris Barber, reflects on 2020 and shares plans for the year ahead Read More »

Collaboration Innovation Working together data sharing

Anticipating and supporting the needs of our members

As a member-based organisation, anticipating and supporting the needs of our members is critical. To give context to this I’d like to highlight two examples of this in action: The development of a statistical-based methodology for the prediction of Mutagenicity; Sarah Nexus. In the mid to late 2000s individual regulators had issued guidelines allowing the

Anticipating and supporting the needs of our members Read More »